ICON Selected by Eli Lilly and Company to Oversee its Clinical Data Management in Japan

DUBLIN--(BUSINESS WIRE)--ICON plc, (NASDAQ:ICLR), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced that it has signed an extension to its strategic agreement with Eli Lilly and Company (NYSE:LLY) to manage the company’s clinical data management outside the US. This extension means that ICON will now also manage Lilly’s needs in Japan in addition to those in Europe, Canada, Latin America, Australia and Asia, which was originally agreed in November 2008. Lilly also selected ICON to manage clinical trial site set up and monitoring in Europe for Lilly managed studies in June 2009.